Tenet Healthcare Corporation

Health System with 29 hospitals across 10 states

Health System Overview

Health System	Tenet Healthcare Corporation
Total Hospitals	29
Commercial/Acute Hospitals	29
Total Beds	7534
Commercial/Acute Beds	7534
Headquarters	Turlock, CA
Website	tenethealth.com

Hospitals by Type

Acute Care Hospital

29 hospitals

100% of health system

Teaching Status

41%

Teaching

Teaching Hospitals: 12

Non-Teaching Hospitals: 17

Teaching hospitals serve as educational institutions for medical professionals while providing patient care.

Hospital Locations

Hospitals in this Health System

Hospital	Type	Beds	Teaching	Recently Joined
Abrazo Central Campus	Acute Care Hospital	206	No	No
Abrazo Scottsdale Campus	Acute Care Hospital	136	Yes	No
Abrazo Arrowhead Campus	Acute Care Hospital	217	Yes	No
Abrazo West Campus	Acute Care Hospital	200	Yes	No
Doctors Hospital of Manteca	Acute Care Hospital	71	No	No
Emanuel Medical Center	Acute Care Hospital	354	No	No
Desert Regional Medical Center	Acute Care Hospital	385	Yes	No
Hi-Desert Medical Center	Acute Care Hospital	59	No	No
Doctors Medical Center of Modesto	Acute Care Hospital	461	Yes	No
JFK Memorial Hospital	Acute Care Hospital	156	No	No
Palm Beach Gardens Medical Center	Acute Care Hospital	199	No	No
Delray Medical Center	Acute Care Hospital	536	No	No
West Boca Medical Center	Acute Care Hospital	195	No	No
Good Samaritan Medical Center	Acute Care Hospital	333	No	No
St Mary's Medical Center	Acute Care Hospital	413	No	No
Metrowest Medical Center	Acute Care Hospital	360	Yes	No
Saint Vincent Hospital	Acute Care Hospital	283	Yes	No
DMC Harper University Hospital	Acute Care Hospital	712	Yes	No
Oklahoma Center for Orthopaedic & Multi-Specialty Surgery	Acute Care Hospital	9	Yes	No
Piedmont Medical Center	Acute Care Hospital	288	No	No
Dunes Surgical Hospital	Acute Care Hospital	38	No	No
St. Francis Hospital	Acute Care Hospital	519	Yes	No
Saint Francis Hospital - Bartlett	Acute Care Hospital	196	No	No
The Hospitals of Providence - Memorial Campus	Acute Care Hospital	486	Yes	No
Valley Baptist Medical Center - Brownsville	Acute Care Hospital	240	No	No
Nacogdoches Medical Center	Acute Care Hospital	140	No	No
The Hospitals of Providence - East Campus	Acute Care Hospital	218	No	No
The Hospitals of Providence Transmountain Campus	Acute Care Hospital	108	Yes	No
The Hospitals of Providence - Horizon City Campus	Acute Care Hospital	16	No	No

Recent News

Jun 13, 2025

A recent ruling by the U.S. District Court for the Eastern District of California has allowed a putative class action lawsuit against Tenet Healthcare Corporation and related entities to proceed, although some claims were trimmed. The lawsuit alleges that several of Tenet's California hospitals improperly shared sensitive patient information with third parties. This sharing is claimed to have occurred through the use of online tracking technologies, such as Meta Pixel and Google Analytics, on the hospitals' websites, which were allegedly used for advertising purposes. The court's decision means that Tenet must defend against the core allegations that its data disclosure practices violated patient privacy, impacting individuals whose information was potentially shared without their explicit consent. This development is significant for Tenet's operations in California, including Emanuel Medical Center in Turlock, as the ruling applies to the corporation's hospitals within the state. While specific details about the impact on individual Tenet facilities like Emanuel Medical Center are not provided in the immediate reporting of the court's decision, the lawsuit itself pertains to the practices of Tenet's California hospitals collectively. The trimming of some claims by the court suggests a narrowing of the scope of the lawsuit, but the central assertion regarding improper data sharing remains active. Tenet had sought to dismiss the lawsuit, arguing that the claims duplicated those from a previous legal action, but the court only partially agreed with this assertion.

Jun 07, 2025

Richard Fisher, a Director at Tenet Healthcare Corp (THC), sold 836 shares of the company's stock on June 5, 2025. Following this transaction, Fisher now holds 11,292 shares of Tenet Healthcare. This detail was reported in an SEC Filing. Over the past year, Richard Fisher has sold a total of 7,313 shares and has not made any purchases. The insider transaction history for Tenet Healthcare Corp indicates a pattern of insider selling, with 0 insider buys and 19 insider sells recorded over the same one-year period. On the day of this recent sale, Tenet Healthcare Corp shares were trading at $173.16, giving the company a market capitalization of $15.926 billion. The company's price-earnings ratio at the time was 11.34, which is below the industry median and the company's historical median. Based on a price of $173.16 and a GuruFocus Value of $88.79, Tenet Healthcare's stock is considered significantly overvalued with a price-to-GF-Value ratio of 1.95. [5]

Jun 06, 2025

New insider activity at Tenet Healthcare (THC) occurred on June 6, 2025, involving stock sales by top executives. Paola M Arbour, EVP & CIO, sold 7,738 shares of Tenet Healthcare stock for a total of $1,338,674. Additionally, Director Richard W. Fisher sold 836 shares, totaling $144,761. This follows recent developments at the company, including the announcement of Lisa Y. Foo's promotion to Chief Operating Officer, a move anticipated to strengthen operational leadership. Analysts have also recently adjusted their price targets for Tenet Healthcare, reflecting varied outlooks. Barclays raised its price target due to concerns regarding Medicare Part D and ACA businesses, citing potential negative earnings risks from possible premium increases and market disruptions. Conversely, Wells Fargo upgraded Tenet to Overweight, suggesting reduced policy risks after budget reconciliation legislation might lead to manageable impacts from healthcare spending cuts. Despite facing challenges, Tenet's financial performance, including strong EBITDA growth and strategic capital management, continues to support its appeal, although revenue growth and policy uncertainties remain areas needing attention. According to Spark, TipRanks' AI Analyst, THC is rated as Outperform, driven primarily by its strong operational efficiency and profitability, positive earnings momentum, and strategic corporate events, despite potential risks from valuation concerns and policy uncertainties. [4]

Jun 04, 2025

In the latest trading session on June 4, 2025, Tenet Healthcare (THC) stock closed at $169.89, showing a slight decrease of -1.13% from its previous closing price. This performance lagged behind the S&P 500, which saw a daily gain of 0.01%. The Dow experienced a decline of 0.22%, while the Nasdaq increased by 0.32%. Despite the recent daily dip, Tenet Healthcare's shares have performed well over the past month, appreciating by 13.44%. This outperforms the Medical sector, which had a loss of 2.72%, and the S&P 500, which gained 5.2% over the same period. Investors are anticipating Tenet Healthcare's upcoming earnings release, with projections for earnings per share (EPS) at $2.84, representing a 22.94% increase compared to the same quarter last year. Revenue is estimated to be around $5.15 billion, a projected increase of 0.85% year-over-year. [3]

May 31, 2025

James L. Bierman, a director at Tenet Healthcare Corp (NYSE:THC), sold 4,613 shares of company stock on May 29, 2025, at a price of $170 per share, totaling approximately $784,210. This transaction was conducted under a prearranged 10b5-1 trading plan, which is a common tool allowing company insiders to sell stocks legally. [7] Following this sale, Bierman still holds 35,271 shares of Tenet Healthcare. [7] At the time of the sale, Tenet's stock was trading near its 52-week high of $171.20 and had delivered a year-to-date return of 33.7%. [7] Analysis from InvestingPro suggested the stock's Relative Strength Index (RSI) indicated it was in overbought territory. [7] This news followed recent positive analyst updates, including BofA Securities raising its price target to $180 with a Buy rating, and Cantor Fitzgerald reaffirming its Overweight rating with a $177 price target, both citing the company's strong performance and focus on expanding its Ambulatory Surgery Center (ASC) business. [7]

Executive Leadership

No Contacts Found on Health System Web Page—HealthLuminate Provides Over 300K Hospital Leaders in Our Extended Database.